A clear Ipamorelin research vial on a coloured plaster ledge, with botanicals beside it

About this compound

Ipamorelin is a synthetic pentapeptide and a selective agonist at the growth hormone secretagogue receptor GHS-R1a, the same receptor targeted by ghrelin.

Studied in

  • Ghrelin receptor selectivity
  • Secretagogue pharmacology

Compound identity

CompoundIpamorelin
CAS number170851-70-4
Molecular formulaC38H49N9O5
Molecular weight711.86 Da

Specifications

  • Purity method: HPLC
  • Appearance: Lyophilized powder
  • Solubility: Reconstitute per protocol; see Supplies for diluents.
  • We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.

Endocrine

SCALPEL

Ipamorelin

Selective GH secretagogue, studied for receptor specificity.

What the research targets

Studied for high selectivity at the ghrelin receptor with minimal cross-reactivity in secretagogue-receptor panels.

Supply formats

Single units ship from stock. Cases are back-ordered against the same single-unit price.

Stick is newly released — available alongside the vial on every compound.

Single unit

Sample quantity — one unit.

  • 10 mgVial

    PS-2146000-10-MG

    On verified account
  • Skinni Stick™ 10 mgSkinni Stick™New

    Single-compound Skinni Stick™. Supplied to verified accounts only.

    PS-2146000-PEN-10-MG

    On verified account

Case — back-order

Ten of one size, at 10× volume pricing.

  • Case · 10 × 10 mg

    Back-order — 15% off the single-unit price.

    PS-2146000-C10-10-MG

    On verified account
  • Case · 10 × Skinni Stick™ 10 mgNew

    Back-order — 15% off the single-unit price.

    PS-2146000-C10-PEN-10-MG

    On verified account

One-time verification of professional or institutional affiliation. No payment is taken on this site.

Research use only

This compound is supplied exclusively for laboratory research by qualified professionals and institutions. It is not a drug, dietary supplement, or cosmetic, and is not for human or veterinary use. We publish no dosing, administration, or human-use guidance of any kind, and nothing here should be read as a claim about an effect in people.

From the research library

Cited summaries of the published work behind Ipamorelin — what was studied, in which model, and what was measured.

All articles

More in Endocrine